Cost-saving overhaul by Novo Nordisk follows profit warning, fierce competition in obesity drug market
(Newser) -
Novo Nordisk, the Danish pharmaceutical giant known for manufacturing Ozempic and Wegovy, has announced plans to slash about 9,000 jobs—roughly 11% of its global workforce—in an effort to streamline operations and rein in costs. The company says the cuts will take place immediately, and that staffers...